Stratec SE (LON:0RAR)

Market Cap	238.55M -24.7%
Revenue (ttm)	210.80M -7.1%
Net Income	-340.13K
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	14.76
Dividend	0.52 (2.65%)
Ex-Dividend Date	Jun 24, 2026

Volume	11
Open	22.40
Previous Close	22.55
Day's Range	22.40 - 23.10
52-Week Range	16.34 - 32.85
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is h...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 1,383
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RAR

Financial Performance

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error